Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Canagliflozin Tablets

Approval Number

国药准字H20233077

Company杭州中美华东制药有限公司

Registration Date

January 19, 2023

Drug Information

Generic Name

卡格列净片

Dosage Form

片剂

Strength

0.1g（按C₂₄H₂₅FO₅S计）

Drug Type

化学药品

Registration Date

January 19, 2023

Company Information

Applicant Company

Company Name杭州中美华东制药有限公司

Company Address

杭州市莫干山路866号祥符桥

Manufacturing Company

Company Name杭州中美华东制药有限公司

Company Address

杭州市莫干山路866号祥符桥

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

卡格列净片 - NMPA 批准文号 | MedPath